Cresco Labs (CRLBF) Operating Income Growth (3y) (2023 - 2026)
Cresco Labs (CRLBF) Operating Income Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.33 Bn | 87.46 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.86 Bn | 32.12 Bn | 1.97 Bn | 273.62% |
| 3 | Zoetis | 32.54 Bn | 30.60 Bn | 1.62 Bn | 3.84% |
| 4 | Takeda Pharmaceutical | 27.63 Bn | 23.57 Bn | 4.39 Bn | -59.82% |
| 5 | United Therapeutics | 23.12 Bn | 20.96 Bn | 648.10 Mn | 4.63% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn | -30.05% |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn | 54.58% |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | 40.17% |
| 10 | Cresco Labs | 240.43 Mn | 176.85 Mn | 75.45 Mn | 46.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.06% |
| Dec 31, 2025 | 19.25% |
| Sep 30, 2025 | 3.16% |
| Jun 30, 2025 | -10.71% |
| Mar 31, 2025 | -12.47% |
| Dec 31, 2024 | 7.65% |
| Sep 30, 2024 | 28.05% |
| Jun 30, 2024 | 29.61% |
| Mar 31, 2024 | 21.55% |
| Dec 31, 2023 | 335.10% |
| Sep 30, 2023 | -84.90% |
| Jun 30, 2023 | 19.92% |
| Mar 31, 2023 | 28.65% |